Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
- PMID: 36595298
- PMCID: PMC9857170
- DOI: 10.1001/jamanetworkopen.2022.49810
Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
Plain language summary
This quality improvement study evaluates access to oral COVID-19 therapeutics within communities in the 48 contiguous states and the District of Columbia.
Conflict of interest statement
Figures
References
-
- Kaiser Family Foundation . How equitable is access to COVID-19 treatments? Accessed July 20, 2022. https://www.kff.org/coronavirus-covid-19/issue-brief/how-equitable-is-ac...
-
- US Department of Health & Human Services . COVID-19 public therapeutic locator. Accessed July 20, 2022. https://healthdata.gov/Health/COVID-19-Public-Therapeutic-Locator/rxn6-qnx8
-
- US Census Bureau . TIGER/Line shapefiles. Accessed July 20, 2022. https://www.census.gov/geographies/mapping-files/time-series/geo/tiger-l...
-
- Open Source Routing Machine. Accessed July 20, 2022. http://project-osrm.org/
-
- OpenStreetMap . Accessed July 20, 2022. https://www.openstreetmap.org
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical